BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32005345)

  • 1. Pro-metastatic functions of Notch signaling is mediated by CYR61 in breast cells.
    Ilhan M; Kucukkose C; Efe E; Gunyuz ZE; Firatligil B; Dogan H; Ozuysal M; Yalcin-Ozuysal O
    Eur J Cell Biol; 2020 Apr; 99(2-3):151070. PubMed ID: 32005345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH.
    Gründker C; Bauerschmitz G; Schubert A; Emons G
    Int J Oncol; 2016 Jun; 48(6):2713-21. PubMed ID: 27098123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baicalein Inhibits Epithelial to Mesenchymal Transition via Downregulation of Cyr61 and LOXL-2 in MDA-MB231 Breast Cancer Cells.
    Nguyen LT; Song YW; Cho SK
    Mol Cells; 2016 Dec; 39(12):909-914. PubMed ID: 28008161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyr61 as mediator of Src signaling in triple negative breast cancer cells.
    Sánchez-Bailón MP; Calcabrini A; Mayoral-Varo V; Molinari A; Wagner KU; Losada JP; Ciordia S; Albar JP; Martín-Pérez J
    Oncotarget; 2015 May; 6(15):13520-38. PubMed ID: 25980494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61.
    Harris LG; Pannell LK; Singh S; Samant RS; Shevde LA
    Oncogene; 2012 Jul; 31(28):3370-80. PubMed ID: 22056874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo.
    Lin J; Huo R; Wang L; Zhou Z; Sun Y; Shen B; Wang R; Li N
    Cancer Immunol Immunother; 2012 May; 61(5):677-87. PubMed ID: 22048717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis.
    Huang YT; Lan Q; Lorusso G; Duffey N; Rüegg C
    Oncotarget; 2017 Feb; 8(6):9200-9215. PubMed ID: 27911269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Snail/FOXK1/Cyr61 Signaling Axis Regulates the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
    Huang X; Xiang L; Li Y; Zhao Y; Zhu H; Xiao Y; Liu M; Wu X; Wang Z; Jiang P; Qing H; Zhang Q; Liu G; Zhang W; Li A; Chen Y; Liu S; Wang J
    Cell Physiol Biochem; 2018; 47(2):590-603. PubMed ID: 29794466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of cysteine-rich protein 61 in the epidermal growth factor-induced migration of human anaplastic thyroid cancer cells.
    Chin LH; Hsu SP; Zhong WB; Liang YC
    Mol Carcinog; 2016 May; 55(5):622-32. PubMed ID: 25773758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process.
    Habel N; Stefanovska B; Carène D; Patiño-Garcia A; Lecanda F; Fromigué O
    BMC Cancer; 2019 Jan; 19(1):62. PubMed ID: 30642298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway.
    Menendez JA; Vellon L; Mehmi I; Teng PK; Griggs DW; Lupu R
    Oncogene; 2005 Jan; 24(5):761-79. PubMed ID: 15592521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-33a Mediates the Anti-Tumor Effect of Lovastatin in Osteosarcoma by Targeting CYR61.
    Huang Y; Zhang J; Shao H; Liu J; Jin M; Chen J; Zhao H
    Cell Physiol Biochem; 2018; 51(2):938-948. PubMed ID: 30466075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative splicing of Cyr61 is regulated by hypoxia and significantly changed in breast cancer.
    Hirschfeld M; zur Hausen A; Bettendorf H; Jäger M; Stickeler E
    Cancer Res; 2009 Mar; 69(5):2082-90. PubMed ID: 19244129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer.
    Vellon L; Menendez JA; Lupu R
    Oncogene; 2005 May; 24(23):3759-73. PubMed ID: 15782133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch1 induces epithelial-mesenchymal transition and the cancer stem cell phenotype in breast cancer cells and STAT3 plays a key role.
    Zhang X; Zhao X; Shao S; Zuo X; Ning Q; Luo M; Gu S; Zhao X
    Int J Oncol; 2015 Mar; 46(3):1141-8. PubMed ID: 25544568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
    Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch-1 signaling activates NF-κB in human breast carcinoma MDA-MB-231 cells via PP2A-dependent AKT pathway.
    Li L; Zhang J; Xiong N; Li S; Chen Y; Yang H; Wu C; Zeng H; Liu Y
    Med Oncol; 2016 Apr; 33(4):33. PubMed ID: 26945854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells.
    Suman S; Das TP; Damodaran C
    Br J Cancer; 2013 Nov; 109(10):2587-96. PubMed ID: 24129237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of miR9/NOTCH1 interaction reduces metastatic behavior in triple-negative breast cancer.
    Mohammadi-Yeganeh S; Mansouri A; Paryan M
    Chem Biol Drug Des; 2015 Nov; 86(5):1185-91. PubMed ID: 25963903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.